Drugs to interfere with orexins (hypocretins)

Area of Science:

• Neuroscience
• Pharmacology
• Endocrinology

Background:

• Orexins (hypocretins) are key neuropeptides regulating arousal, appetite, and neuroendocrine-autonomic functions.
• Orexin system dysfunction is implicated in narcolepsy and cataplexy.
• The orexin system integrates diverse neurohumoral signals, including neurotransmitters, metabolic, circadian, and immunological factors.

Purpose of the Study:

• To review drugs directly and indirectly targeting the orexin system.
• To explore pharmacological targets within the orexin network.
• To understand the orexin system's role in behavioral state, stress, energy homeostasis, and survival.

Main Methods:

• Review of existing literature on orexin system pharmacology.
• Analysis of direct orexin receptor agonists and antagonists.
• Examination of drugs for narcolepsy-cataplexy and their indirect effects on orexins.

Main Results:

• Identification of novel selective orexin receptor agonists and antagonists.
• Elucidation of drugs targeting the complex network of signals modulated by orexins.
• Understanding of orexin system's integration of various physiological and environmental inputs.

Conclusions:

• Targeting the orexin system offers therapeutic potential for narcolepsy and related disorders.
• Further research into orexin system modulation can advance treatments for sleep, eating, mood, and memory disorders.
• Basic and clinical evaluations are crucial for understanding orexin's role in fundamental physiological processes.